Miriam Hospital's HVTU

Providence, Rhode Island 02906

0 studies enrolling now · 11 studies all time

What they study most

HIV Infections, HIV Seronegativity

Studies at this site

• Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B — Completed
• HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants — Completed
• An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV — Completed
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults — Completed
• Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults — Completed
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults — Completed
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults — Completed
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines — Completed
• Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052 — Completed
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults — Completed
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults — Completed